Cytokine Sensitivity of Langerhans' Islets of Diabetes-prone BB/OK Rats under Hypoglycemic Conditions

References

• Nakhooda, AF., Like, A.A., Chappel, CI., Murray, FT. and Marliss, E.B. (1977) "The spontaneously diabetic Wistar rat. Metabolic and morphological studies", Diabetes 26, 100–112.
   PubMed Web of Science ®Google Scholar
• Marliss, E.B., Nakhooda, A.F., Poussier, P. and Sima, A.A.F. (1982) "The diabetic syndrome of the BB Wistar rat: possible relevance to type I (insulin-dependent) diabetes in man", Diabetologia 22, 225–232.
   PubMed Web of Science ®Google Scholar
• Klöting, I. and Vogt, L. (1991) "BB/0(ttawa) K(arlsburg) rats: features of a sublime of diabetes-prone BB rats", Diabetes Res. 18, 79–87.
   PubMedGoogle Scholar
• Fuks, A., Ono, S.J., Colle, E. and Guttman, RD. (1990) "A single dose of the MHC-linked susceptibility determinant associated with the RT1u haplotype is permissive for insulin-dependent diabetes mellitus in the BB rat", Exp. Clin. Immunogenet. 7, 162–169.
   PubMedGoogle Scholar
• Kliiting, I., Vogt, L. and Serikawa, T. (1995) "Locus on chromosome 18 cosegregates with diabetes in the BB/OK rat subline", Diabetes Metab. 21, 338–344.
   Google Scholar
• Kliiting, I., van den Brand, J. and Kuttler, B. (2001) "Genes of SHR rats protect spontaneously diabetic BB/OK rats from diabetes: lessons from congenic BB-SHR rat strains", Biochem. Biophys. Res. Commun. 283, 399–405.
   PubMedGoogle Scholar
• MacKay, P. (1995) "Adoptive transfer of diabetes to and from old normoglycaemic BB rats", Diabetologia 38, 145–152.
   PubMedGoogle Scholar
• Iwakoshi, N.N., Greiner, DL., Rossini, A.A. and Mordes, J.P. (1999) "Diabetes prone BB rats are severely deficient in natural killer T cells", Autoimmunity 31, 1–14.
   PubMed Web of Science ®Google Scholar
• Ellerman, K.E. and Like, A.A. (1999) "Islet cell membrane antigens activate diabetogenic CD4+ T-cells in the BB/Wor rat", Diabetes 48, 975–982.
   PubMed Web of Science ®Google Scholar
• Spinas, GA., Palmer, J.P., Mandrup-Poulsen, T., Andersen, H., Nielsen, J.H. and Nerup, J. (1988) "The bimodal effect of interleukin 1 on rat pancreatic beta-cells —stimulation followed by inhibition —depends upon dose, duration of exposure, and ambient glucose concentration", Acta Endocrinol. (Copenh) 119, 307–311.
   PubMedGoogle Scholar
• Eizirik, D.L. (1988) "Interleukin-1 induced impairment in pancreatic islet oxidative metabolism of glucose is potentiated by tumor necrosis factor", Acta Endocrinol. (Copenh) 119, 321–325.
   PubMedGoogle Scholar
• Delany, C.A., Green, M.H.L., Lowe, J.E. and Green, LC. (1993) "Endogenous nitric oxide induced by interleukin-113 in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the 'comet' assay", FEBS Lett. 333, 291–295.
   PubMedGoogle Scholar
• Dunger, A., Schröder, D., Augstein, R, Wittstruck, T., Wachlin, G., Vogt, L., Ziegler, B. and Schmidt, S. (1995) "Impact of metabolic activity of beta cells on cytokine-induced damage and recovery of rat pancreatic islets", Acta Diabetol. 32, 217–224.
   PubMedGoogle Scholar
• Kolb, H., Worz-Pagenstert, U., Kleemann, R., Rothe, H., Rowsell, R and Scott, F.W. (1996) "Cytokine gene expression in the BB rat pancreas: natural course and impact of bacterial vaccines", Diabetologia 39, 1448–1454.
   PubMed Web of Science ®Google Scholar
• El-Sheikh, A., Suarez-Pinzon, W.L., Power, RE and Rabinovitch, A. (1999) "Both CD4+ and CD8+ T cells are required for 1FN-y gene expression in pancreatic islets and autoämnune diabetes development in Biobreeding rats", J. Autoimmun. 12, 109–119.
   PubMedGoogle Scholar
• Gotfredsen, C.F., Buschard, K. and Frandsen, E.K. (1985) "Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes prone animals", Diabetologia 28, 933–935.
   PubMed Web of Science ®Google Scholar
• Klöting, I., Sadewasser, S., Lucke, S., Vogt, L. and Hahn, H.J. (1988) "Development of BB rat diabetes is delayed or prevented by infections or applications of immunogens", In: Shafrir, E., ed, Frontiers in Diabetes Research. Lessons from Animal Diabetes 11 (J. Libbey, London, Paris), pp 190–194.
   Google Scholar
• Schröder, D., Ratke, M., Bauer, U.Ch., Klöting, I., Ziegler, B. and Schmidt, S. (2002) "Prophylactic insulin treatment of diabetes-prone BB/OK rats by application of a sustained release insulin implant", Autoimmunity 35, 143–153.
   PubMed Web of Science ®Google Scholar
• Bertrand, S., De Paepe, M., Vigeant, C. and Yale, J.F. (1992) "Prevention of adoptive transfer in BB rats by prophylactic insulin treatment", Diabetes 41, 1273–1277.
   PubMedGoogle Scholar
• Gottlieb, RA., Handler, ES., Appel, MC., Greiner, DL., Mordes, J.P. and Rossini, A.A. (1991) "Insulin treatment prevents diabetes mellitus but not thyroiditis in RT6-depleted diabetes resistant BB/Wor rats", Diabetologia 34, 296–300.
   PubMedGoogle Scholar
• Buschard, K., Brogren, C.H., Ropke, C. and Rygaard, J. (1988) "Antigen expression of the pancreatic beta-cells is dependent on their functional state, as shown by a specific, BB rat monoclonal antibody IC2", APMIS 96, 342–346.
   PubMed Web of Science ®Google Scholar
• Björk, E., Kämpe, 0., Grawe, J., Hallberg, A., Norheim, I. and Karlsson, F.A. (1993) "Modulation of beta-cell activity and its influence on islet cell antibody (ICA) and islet cell surface (ICSA) reactivity", Autoimmunity 16, 181–188.
   PubMed Web of Science ®Google Scholar
• Kliiting, I., Voigt, B. and Vogt, L. (1995) "Molecular analysis of diabetes-prone BB rat sublines and derivatives of their common ancestor as a tool to search for candidate loci causing different phenotypes in BB rats", Diabetes Res. 29, 64–71.
   Google Scholar
• Hehmke, B., Kohnert, K.D. and Odselius, R. (1986) "The use of a new dextran gradient medium for rapid isolation of functionally intact neonatal rat pancreatic islets", Diabetes Res. 3, 13–16.
   PubMedGoogle Scholar
• Jahr, H., Schröder, D., Ziegler, B., Ziegler, M. and Ziihlke, H. (1980) "Transcriptional and translational control of glucose-stimulated (pro)insulin biosynthesis", Eur. J. Biochem. 10, 499–505.
   Google Scholar
• Besch, W., Woltanski, KR, Keilacker, H., Diaz-Alonso, J.M., Schulz, B., Amend, R, Kohnert, K.D. and Ziegler, M. (1987) "Measurement of insulin in human sera using a new RIA Kit 1. Insulin determination in the absence of insulin antibodies — conventional assay and micro modification", Exp. ClM. Endocrinol. 90, 264–270.
   Google Scholar
• Unger, R.H., Eisentraut, AM. and Madison, L.L. (1963) "The effects of total starvation upon the levels of circulating glucagon and insulin in man", J. ClM. Invest. 42, 1031–1039.
   PubMed Web of Science ®Google Scholar
• Liljenquist, J.E., Horwitz, DL., Jennings, AS., Chiasson, J.L., Keller, U. and Rubenstein, A.H. (1978) "Inhibition of insulin secretion by exogenous insulin in normal man as demonstrated by C-peptide assay", Diabetes 27, 563–570.
   PubMedGoogle Scholar
• Chen, L., Komiya, I., Inman, L., O'Neil, J., Appel, M., Alam, T. and Unger, R.H. (1989) "Effects of hypoglycemia and prolonged fasting on insulin and glucagon gene expression: studies with in situ hybridization", J. Clin. Invest. 84, 711–714.
   PubMedGoogle Scholar
• Rabinovitch, A., Pukel, C. and Baquerizo, H. (1988) "Interleukin-1 inhibits glucose- modulated insulin and glucagon secretion in rat islet monolayer cultures", Endocrinology 122, 2393–2398.
   PubMed Web of Science ®Google Scholar
• Corbett, LA., Wang, J.L., Sweetland, MA., Lancaster, Jr., J.R. and McDaniel, M.L. (1992) "Interleukin 113 induces the formation of nitric oxide by 13-cells purified from rodent islets of Langerhans. Evidence for the I3-cells as a source and site of action of nitric oxide", J. Clin. Invest. 90, 2384–2391.
   Google Scholar
• Dunger, A., Cunningham, J.M., Delaney, C.A., Lowe, J.E., Green, M.H.L., Bone, A.J. and Green, LC. (1996) "Tumor necrosis factor-a and interferon-fly inhibit insulin secretion and cause DNA damage in unweaned-rat islets. Extent of nitric oxide involvement", Diabetes 45, 183–189.
   PubMed Web of Science ®Google Scholar
• Sternesjii, J., Bendtzen, K. and Sandler, S. (1995) "Effects of prolonged exposure in vitro to interferon--y and tumor necrosis factor-a on nitric oxide and insulin production of rat pancreatic islets", Autoimmunity 20, 185–190.
   PubMedGoogle Scholar
• Southern, C., Schulster, D. and Green, LC. (1990) "Inhibition of insulin secretion by interleukin-113 and tumor necrosis factor-a viaan L-arginine-dependent nitric oxide generating mechanism", FEBS Lett. 276, 42–44.
   PubMed Web of Science ®Google Scholar
• Corbett, J.A., Lancaster, Jr., J.R., Sweetland, MA. and McDaniel, M.L. (1991) "Interleukin-113-induced formation of ERP-detectable iron-nitrosyl complexes in islets of Langerhans", J. Biol. Chem. 266, 21351–21354.
   Google Scholar
• Sandler, S., Bendtzen, K., Borg, L.A.H., Eizirik, DL., Strandell, E. and Welsh, N. (1989) "Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-113 indicate a pertubation in the mitochondrial function", Endocrinology 124, 1492–1501.
   PubMed Web of Science ®Google Scholar
• Welsh, N., Eizirik, DL., Bendtzen, K. and Sandler, S. (1991) "Interleukin-113-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase", Endocrinology 129, 3167–3173.
   PubMed Web of Science ®Google Scholar
• Koranyi, L., James, D.E., Kraegen, E.W. and Permutt, MA. (1992) "Feedback inhibition of insulin gene expression by insulin", J. Clin. Invest. 89, 432–436.
   PubMedGoogle Scholar
• Marchetti, P., Scharp, D.W., Mclear, M., Finke, E.H., Olack, B., Swanson, C., Giannarelli, R., Navalesi, R. and Lacy, P.E. (1995) "Insulin inhibits ist own secretion from isolated, perifused human pancreatic islets", Acta Diabetol. 32, 75–77.
   PubMedGoogle Scholar